Pour plus de facilité, laissez cette case cochée. Sur les appareils partagés, nous vous conseillons de vous déconnecter d'Euroquity à la fin de votre utilisation
Email

Vous allez recevoir un email pour créer un nouveau mot de passe

Localisation

Choisissez votre pays

et votre langue

Bonjour ,

Bienvenue sur votre profil personnel. Votre carte de visite professionnelle présente votre activité principale. Elle sera visible sur EuroQuity.

% complété

%

medal 2
Ce profil est validé par 2 label.

Company

AMONETA DIAGNOSTICS

AMONETA DIAGNOSTICS_logo
17
EQ SCORE

L'EQ Score indique l'activité et l'attractivité de l'entreprise sur la plateforme : complétude du profil, actualités, likes, follows, appartenance à un ou plusieurs labels ou communautés, nombre de membres de son réseau, etc.

Amoneta Diagnostics offers a blood diagnostic test to detect and follow the Alzheimer’s Disease pathology, which shall also be used as an optimizing method for present and future treatments and drug development projects.

Huningue, Grand-Est, France

Send a message

Anglais

AMONETA DIAGNOSTICS

Anglais

Amoneta offers a unique diagnostic test for an unmet, high medical need: Reliable early diagnosis of Alzheimer's Disease.

The test is performed on a minimal blood sample, based on the detection of two complementary biomarkers. The first results show a reliability up to 95% in human subjects, even 100% in animals. The competitive advantages of ADDIA test are (1) the ease of implementation, rapid, minimally invasive, effective laboratory routine and inexpensive, (2)...

See more

Amoneta offers a unique diagnostic test for an unmet, high medical need: Reliable early diagnosis of Alzheimer's Disease.

The test is performed on a minimal blood sample, based on the detection of two complementary biomarkers. The first results show a reliability up to 95% in human subjects, even 100% in animals. The competitive advantages of ADDIA test are (1) the ease of implementation, rapid, minimally invasive, effective laboratory routine and inexpensive, (2) reliability, compared to all existing competitor tests (3) repeatability, the fact that it can be repeated without bias, unlike neuropsychological tests.

Compared to competitor companies developing blood biomarkers, Amoneta is ahead as it is the only company so far with clinical development on 1024 patients being recruited in its late stage clinical studies.

  • 1

    Like

Our latest news

Certifications

InvestHorizon - Accelerated
The InvestHorizon Accelerated label is for selected deep tech companies from the accelerator programme to facilitate series A funding.  This quality label is a guarantee for investors to find high standard project proposals from European SMEs with growth potential. InvestHorizon is a programme financed by the European Commission in association with Eureka to foster investment readiness.
161 Entities

Communities

France Angels
France Angels est la Fédération nationale des Business Angels France Angels agit pour promouvoir les Business Angels dans les domaines économiques, sociaux et juridiques pour faire reconnaître leur utilité, leur effet positif sur l'économie et légitimer leur action.
410 Members
InvestHorizon
InvestHorizon is an accelerator programme designed to facilitate the access to Series A funding for selected DEEP TECH companies.
1217 Members

Our history

Start in 2014

  • 2014

    Amoneta Diagnostics SAS is founded by Firalis SA and SODIV.

  • 2015

    ADDIA Project proposal has been awarded with a "Seal of Excellence" and a 5 Mio € grant by the EU.

  • 2016

    Amoneta obtained approvals from various ethic committee for its ADDIA multicentric clinical study.

  • Jan-2017

    Amoneta launched its ADDIA multicentric study aiming to do the proof-of-performance of its test.

  • Mar-2018

    Strasbourg Hospital finalized recruitments for the Chronobiological study (part of ADDIA Program).

to be continued ...